Duinig, Rosalie L.
HRN: 21-18-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2025
CEFUROXIME 1.5GM (VIAL)
05/09/2025
05/10/2025
IVT
1.5 GMS
ON CALL TO OR THEN Q 8HRS
NKA
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes